MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, David A. Barbie, Tetsuo Tani et al.|Cancer Cell|2022Cited by 101
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, David A. Barbie, Haritha Mathsyaraja et al.|Cancer Discovery|2024Cited by 98
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Cancer Immunology Research|2022Cited by 88
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, David A. Barbie, Andrew Portell et al.|Journal of Clinical Investigation|2020Cited by 73
Tumor-Derived cGAMP Regulates Activation of the VasculatureMarco Campisi, David A. Barbie, Shriram K. Sundararaman et al.|Frontiers in Immunology|2020Cited by 61